Novel Marker Shows Promise for Early Detection of Pancreatic Cancer

Email not displaying correctly?
View it in your browser.
G2 LogoLab and Pathology Insider Logo
 
June 30, 2015

U.S. Supreme Court Upholds Nationwide Individual Insurance Subsidies

By Ron Shinkman, Editor, Laboratory Industry Report

The United States Supreme Court ruled Thursday to maintain income-based subsidies that allow millions of Americans to purchase individual health insurance policies from the federal healthcare.gov insurance exchange…

Read more...


Compliance Officers Need Increased Role in Strategic Decisionmaking

By Kelly A. Briganti, Editorial Director, G2 Intelligence

PricewaterhouseCoopers (PwC) announced its fifth annual State of Compliance Survey (2015) indicates corporate compliance officers (CCOs) need to be more involved in strategic decisionmaking—as only one-third of companies report involving the compliance officer in business strategy. "Fulfilling baseline compliance requirements remains a critically important function particularly for industries faced with…

Read more...


NCI-MATCH to Launch Simultaneous Trials of 20+ Targeted Therapies

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies

The precision medicine trial NCI-MATCH (National Cancer Institute-Molecular Analysis for Therapy Choice) will open for patient enrollment in July. The multicenter trial will evaluate the effectiveness of targeted therapies based on genetic mutations, regardless of a patients' cancer type. NCI-MATCH will assess, in parallel, more than…

Read more...


Novel Marker Shows Promise for Early Detection of Pancreatic Cancer

By Stephanie Murg, Managing Director, G2 Intelligence

Tiny particles known as exosomes may be a powerful cancer screening and diagnostic tool—the trick is detecting and isolating those that are derived from cancer cells. Researchers at the University of Texas MD Anderson Cancer Center have done just that, focusing on a protein that is specifically enriched on cancer-cell-derived exosomes and using it to distinguish healthy subjects and patients with a…

Read more...


ABIM Grant Awarded to Reduce Unnecessary Pap Tests

By Kelly A. Briganti, Editorial Director, G2 Intelligence

In keeping with the national focus on reducing unnecessary medical care and getting the right test to the right patient at the right time, the American Board of Internal Medicine (ABIM) Foundation awarded a 34-month grant to a group of Washington state health care organizations. The grant will fund efforts in connection with the Choosing Wisely program…

Read more...


Follow on Twitter  Forward to Friend 

For questions concerning delivery of this email, please contact customer service at: (888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2015, All rights reserved.
Plain Language Media LLLP
PO Box 509
New London, CT
06320